Reference |
---|
Wang W, Srivastava S, Garg A, Xiao C, Hawks S, Pan J, et al. Digital Surface-Enhanced Raman Spectroscopy-Lateral Flow Test Dipstick: Ultrasensitive, Rapid Virus Quantification in Environmental Dust. Environ Sci Technol. 2024;58:4926-4936 pubmed publisher
|
Bae M, Choi S, Kim J, Seo G, Lee Y. Temperature-insensitive label-free SARS-CoV-2 spike protein detection based on complementary refractive index and temperature dependence of multi-mode interference and grating resonance. Talanta. 2024;266:125091 pubmed publisher
|
Chiang W, Stout A, Yanchik Slade F, Li H, Terrando N, Nilsson B, et al. Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Blood-Brain Barrier Damage Relevant to NeuroCOVID Brain Inflammation. ACS Appl Nano Mater. 2023;6:15094-15107 pubmed publisher
|
Hunt A, V xf6 geli B, Hassan A, Guerrero L, Kightlinger W, Yoesep D, et al. A rapid cell-free expression and screening platform for antibody discovery. Nat Commun. 2023;14:3897 pubmed publisher
|
Wang M, Yan H, Chen L, Wang Y, Li L, Zhang H, et al. Oxalic acid blocked the binding of spike protein from SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variants to human angiotensin-converting enzymes 2. PLoS ONE. 2023;18:e0285722 pubmed publisher
|
Zhu J, Yan H, Shi M, Zhang M, Lu J, Wang J, et al. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2. Phytother Res. 2023;37:3508-3521 pubmed publisher
|
Ng E, Choi C, Wang S. Longitudinal analysis of anti-SARS-CoV-2 neutralizing antibody (NAb) titers in vaccinees using a novel giant magnetoresistive (GMR) assay. Sens Actuators B Chem. 2023;387:133773 pubmed publisher
|
Xiang Y, Zhai G, Li Y, Wang M, Chen X, Wang R, et al. Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay. Int J Biol Macromol. 2023;226:780-792 pubmed publisher
|
Chuang S, Buchwald P. Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction from a Chemical Space of Privileged Protein Binders. Pharmaceuticals (Basel). 2022;15: pubmed publisher
|
Mannar D, Saville J, Sun Z, Zhu X, Marti M, Srivastava S, et al. SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization. Nat Commun. 2022;13:4696 pubmed publisher
|
Han J, Lee S, Kim J, Seo G, Lee Y. SARS-CoV-2 spike protein detection using slightly tapered no-core fiber-based optical transducer. Mikrochim Acta. 2022;189:321 pubmed publisher
|
Fu Y, Pan F, Zhao L, Zhao S, Yi J, Cai S. Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses. Int J Biol Macromol. 2022;207:715-729 pubmed publisher
|
Lee J, Lee Y, Lee S, Kim J, Lee C, Kim N, et al. Versatile role of ACE2-based biosensors for detection of SARS-CoV-2 variants and neutralizing antibodies. Biosens Bioelectron. 2022;203:114034 pubmed publisher
|
Heggestad J, Britton R, Kinnamon D, Wall S, Joh D, Hucknall A, et al. Rapid test to assess the escape of SARS-CoV-2 variants of concern. Sci Adv. 2021;7:eabl7682 pubmed publisher
|
Yue S, Li Z, Lin Y, Yang Y, Yuan M, Pan Z, et al. Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody. Front Immunol. 2021;12:751584 pubmed publisher
|
Arroyo R, Grant S, Colombo M, Salvioni L, Corsi F, Truffi M, et al. Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2. Biomolecules. 2021;11: pubmed publisher
|
Long Y, Song S, Luo F, Han X, Hu C, Wang Y, et al. A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding. Biochem Biophys Res Commun. 2021;571:152-158 pubmed publisher
|
Nie J, Xie J, Liu S, Wu J, Liu C, Li J, et al. Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants. Cell Discov. 2021;7:53 pubmed publisher
|
Ramanathan M, Ferguson I, Miao W, Khavari P. SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. Lancet Infect Dis. 2021;21:1070 pubmed publisher
|
Bojadzic D, Alcazar O, Chen J, Chuang S, Condor Capcha J, Shehadeh L, et al. Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2. ACS Infect Dis. 2021;7:1519-1534 pubmed publisher
|
Yu J, Li Z, He X, Gebre M, Bondzie E, Wan H, et al. Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays. J Virol. 2021;: pubmed publisher
|
Ramanathan M, Ferguson I, Miao W, Khavari P. SARS-CoV-2 B.1.1.7 and B.1.351 Spike variants bind human ACE2 with increased affinity. bioRxiv. 2021;: pubmed publisher
|
Bojadzic D, Alcazar O, Buchwald P. Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19. Front Pharmacol. 2020;11:600372 pubmed publisher
|
Lee J, Choi M, Jung Y, Lee S, Lee C, Kim J, et al. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2). Biosens Bioelectron. 2021;171:112715 pubmed publisher
|
Walker S, Chokkalingam N, Reuschel E, Purwar M, Xu Z, Gary E, et al. SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients. J Clin Microbiol. 2020;58: pubmed publisher
|